Have you encountered a difficult target that you could not find a suitable antibody for? We are ready to take on the most challenging antibody generation projects, allowing you to focus on the science.
When you work with us, you'll get access to multiple industry-leading platforms, significantly increasing your chances of finding the right antibody for your application.
RabMAb® technology. A proprietary rabbit monoclonal platform to generate highly specific and sensitive antibodies to a range of antigens, including short peptides, small molecules, point mutations and post-translational modifications.
Next-generation sequencing. Gain insight into the complete antigenic response to discover even rare binders.
AxioMx technology. In vitro recombinant antibody technology allowing antibody generation and affinity maturation in just eight weeks and discovery of binders to targets unsuitable for in vivo approaches. Multi species application capabilities.
Our expert team is ready to guide you every step of the way, ensuring you end up with the optimal antibody for your application. Each custom project is assigned a project manager, who gives you access to a team of experts to help you with every aspect of your project from selecting the right immunogen to downstream manufacturing, assay development, IP management and commercial licensing.
Our experts have successfully concluded more than 3,000 custom projects and are looking forward to supporting you on everything from immunogen design and screening to downstream assay design. To discuss your requirements further, contact a member of our sales partnership team at email@example.com.